Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
8.00
-1.12 (-12.28%)
Jun 2, 2026, 4:00 PM EDT - Market closed
Ernexa Therapeutics Employees
As of December 31, 2025, Ernexa Therapeutics had 7 total employees, including 5 full-time and 2 part-time employees. The number of employees increased by 1 or 16.67% compared to the previous year.
Employees
7
Change (1Y)
1
Growth (1Y)
16.67%
Revenue / Employee
n/a
Profits / Employee
-$1,629,143
Market Cap
9.33M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 7 | 1 | 16.67% | 5 | 2 |
| Dec 31, 2024 | 6 | -2 | -25.00% | 6 | 0 |
| Dec 31, 2023 | 8 | -1 | -11.11% | 8 | 0 |
| Dec 31, 2022 | 9 | -1 | -10.00% | 9 | 0 |
| Dec 31, 2021 | 10 | 0 | - | 10 | 0 |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Bolt Biotherapeutics | 23 |
| BioCardia | 21 |
| BiomX | 20 |
| BioRestorative Therapies | 14 |
| BioVie | 13 |
| Aprea Therapeutics | 8 |
| Immuron | 7 |
| Intensity Therapeutics | 7 |
ERNA News
- 6 days ago - Ernexa Therapeutics plans ERNA-101 investigational new drug submission for Q3 - TheFly
- 6 days ago - Ernexa Therapeutics Successfully Completes Key Manufacturing and IND Preparation Milestones for ERNA-101 Toward First-in-Human Clinical Development - GlobeNewsWire
- 13 days ago - Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Featuring Dr. Elena Ratner Highlighting Ovarian Cancer Landscape and ERNA-101 Opportunity - GlobeNewsWire
- 22 days ago - Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Highlighting Ovarian Cancer Landscape and Lead Candidate ERNA-101 - GlobeNewsWire
- 26 days ago - Ernexa Therapeutics initiated with a Buy at Brookline - TheFly
- 26 days ago - 3 Penny Stocks to Watch Now, 5/7/26 - TipRanks
- 27 days ago - Ernexa Therapeutics announces new ERNA-101 preclinical data - TheFly
- 27 days ago - Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer Models - GlobeNewsWire